
Houdini Bio
Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.
About
Houdini Bio is a DeepTech BioTech company providing critical enabling infrastructure for next-generation genetic medicines. Their platform combines machine learning with a mechanistic understanding of cellular silencing pathways to re-engineer therapeutic DNA. This approach aims to maximize transgene expression, durability, and scalability by making therapeutic DNA invisible to cellular defenses like the Human Silencing Hub (HUSH) complex, thereby improving the effectiveness and safety of genetic therapies.
Key facts
At-a-glance profile data
- Website
- houdinibio.com
- Headquarters
- Cambridge, England, United Kingdom
- Founded
- 2025
- Employees
- 3
- Total funding
- $2M (Pre-Seed)
- Business model
- B2B
Funding rounds
Tech stack
Detected on houdinibio.com, last scanned 10 Sept 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
Frequently asked
How much funding has Houdini Bio raised?
Houdini Bio has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
How many employees does Houdini Bio have?
Houdini Bio has approximately 3 people on record.